EA199800033A1 - Антагонисты канала кальция - Google Patents

Антагонисты канала кальция

Info

Publication number
EA199800033A1
EA199800033A1 EA199800033A EA199800033A EA199800033A1 EA 199800033 A1 EA199800033 A1 EA 199800033A1 EA 199800033 A EA199800033 A EA 199800033A EA 199800033 A EA199800033 A EA 199800033A EA 199800033 A1 EA199800033 A1 EA 199800033A1
Authority
EA
Eurasian Patent Office
Prior art keywords
calcium channel
alkyl
channel antagonists
phenyl
international
Prior art date
Application number
EA199800033A
Other languages
English (en)
Other versions
EA001928B1 (ru
Inventor
Мэрлен Л. Кохен
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800033A1 publication Critical patent/EA199800033A1/ru
Publication of EA001928B1 publication Critical patent/EA001928B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

В настоящем изобретении предложен способ антагонизма или блокирования каналов кальция в тканях сосудов, включающий введение животному, нуждающемуся в лечении, фармацевтически эффективного количества соединения формулы (I)где Rи R, независимо, представляют собой водород, C-C-алкил, -CO-(C-C-алкил), -CHAr или -CO-Ar, где Ar представляет собой фенил или замещенный фенил, Rвыбирают из группы, состоящей из пирролидино, гексаметиленимино и пиперидино, или его фармацевтически приемлемой соли.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800033A 1995-06-07 1996-06-04 Антагонисты канала кальция EA001928B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/485,406 US5840747A (en) 1995-06-07 1995-06-07 Calcium channel antagonists
PCT/US1996/009162 WO1996040134A1 (en) 1995-06-07 1996-06-04 Calcium channel antagonists

Publications (2)

Publication Number Publication Date
EA199800033A1 true EA199800033A1 (ru) 1998-06-25
EA001928B1 EA001928B1 (ru) 2001-10-22

Family

ID=23928032

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800033A EA001928B1 (ru) 1995-06-07 1996-06-04 Антагонисты канала кальция

Country Status (21)

Country Link
US (1) US5840747A (ru)
EP (1) EP0831822B1 (ru)
JP (1) JPH11506788A (ru)
KR (1) KR19990022499A (ru)
CN (1) CN1193274A (ru)
AT (1) ATE252902T1 (ru)
AU (1) AU714403B2 (ru)
CA (1) CA2223711A1 (ru)
CZ (1) CZ288546B6 (ru)
DE (1) DE69630523T2 (ru)
EA (1) EA001928B1 (ru)
ES (1) ES2210373T3 (ru)
HU (1) HUP9900916A3 (ru)
IL (1) IL122459A (ru)
MX (1) MX9709468A (ru)
NO (1) NO975561D0 (ru)
NZ (1) NZ310178A (ru)
PL (1) PL183998B1 (ru)
RO (1) RO116344B1 (ru)
UA (1) UA43895C2 (ru)
WO (1) WO1996040134A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008232A (en) * 1997-08-20 1999-12-28 Eli Lilly And Company Methods for preventing headaches
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
EP1113007A1 (en) 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5447941A (en) * 1993-12-21 1995-09-05 Eli Lilly And Company Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
US5532254A (en) * 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes

Also Published As

Publication number Publication date
ES2210373T3 (es) 2004-07-01
AU714403B2 (en) 2000-01-06
HUP9900916A3 (en) 1999-11-29
PL183998B1 (pl) 2002-08-30
NZ310178A (en) 2000-06-23
EA001928B1 (ru) 2001-10-22
WO1996040134A1 (en) 1996-12-19
EP0831822A4 (en) 2001-12-19
RO116344B1 (ro) 2001-01-30
MX9709468A (es) 1998-04-30
KR19990022499A (ko) 1999-03-25
JPH11506788A (ja) 1999-06-15
NO975561L (no) 1997-12-02
EP0831822B1 (en) 2003-10-29
IL122459A0 (en) 1998-06-15
IL122459A (en) 2001-05-20
CN1193274A (zh) 1998-09-16
DE69630523D1 (de) 2003-12-04
DE69630523T2 (de) 2004-08-12
CA2223711A1 (en) 1996-12-19
EP0831822A1 (en) 1998-04-01
NO975561D0 (no) 1997-12-02
ATE252902T1 (de) 2003-11-15
PL324086A1 (en) 1998-05-11
CZ288546B6 (cs) 2001-07-11
HUP9900916A2 (hu) 1999-09-28
US5840747A (en) 1998-11-24
UA43895C2 (uk) 2002-01-15
AU6091996A (en) 1996-12-30
CZ382897A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
SE9103612D0 (sv) New peptide derivatives
DE69402173T2 (de) Hemmung von Thrombin
YU32196A (sh) Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića
ATE168887T1 (de) Hemmung von dysfunctionalen uterusblutungen
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
EA199900431A1 (ru) Способ профилактики рака молочной железы
DK0652004T3 (da) Fremgangsmåder til behandling af resistente neoplasmer
UA27910C2 (ru) Средство для повышения экспрессии тромбомодулина и повышения активации протеина с
EA199800019A1 (ru) Способ повышения плотности кальциевых каналов
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
EA199800015A1 (ru) Способ ингибирования меланомы
EA199800033A1 (ru) Антагонисты канала кальция
SE9504662D0 (sv) New compounds
EA199800366A1 (ru) Способы ингибирования ингибитора 1 активатора плазминогена
EA199700200A1 (ru) Способы ингибирования рака яичника
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
FI970716A (fi) Menetelmiä primaarisen kohdun limakalvon liikakasvun estämiseksi
ES2131331T3 (es) Uso de benzotiofenos para la preparacion de un medicamento para reducir la formacion de cicatrices en la curacion de heridas.
EA199800575A1 (ru) Производные пиперазина
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9702861A (es) Metodo para inhibir las condiciones asociadas con la bradicinina.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9706072A (es) Metodos de inhibicion de la adhesion celula-celula.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU